Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130201029M |
| Application |
Tumor Marker
|
The kit has been designed for the quantitative determination of PIVKA II (Protein Induced by Vitamin K Absence or Antagonist II) in human serum or plasma. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 600, MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and newly developed MAGLUMI models.Advanced Chemiluminescence TechnologyMAGLUMI PIVKA-II leverages precise chemiluminescence immunoassay technology that enhances laboratory efficiency. By producing accurate and timely results with minimal hands-on time, this system supports high-throughput testing, streamlining workflow and boosting productivity in clinical environments.
Storage and Handling Made EasyThe reagents are specifically designed for stability between 2 to 8 degrees Celsius, making storage convenient for most laboratories. Adhering to these simple storage guidelines preserves reagent integrity, ensuring reliable and repeatable outcomes every time the test is conducted.
Versatile Applications and Real-Time InsightAs a CLIA instrument reagent compatible with MAGLUMI analyzers, PIVKA-II is ideal for laboratories needing swift and dependable measurement. Its real-time operational capability helps in timely diagnosis, offering significant clinical value in routine and specialized testing scenarios.
FAQ's of MAGLUMI PIVKA-AAA (CLIA):
Q: How is the MAGLUMI PIVKA-II (CLIA) reagent used within laboratory settings?
A: The reagent is compatible exclusively with MAGLUMI CLIA analyzers. Laboratories utilize it by following standard assay procedures for chemiluminescence immunoassays, enabling effective detection and quantification of target analytes in real-time.
Q: What benefits does chemiluminescence technology offer compared to other immunoassay methods?
A: Chemiluminescence immunoassay technology provides heightened sensitivity, precise quantification, and fast results. This translates to improved diagnostic confidence and workflow efficiency in clinical laboratories.
Q: When should these reagents be stored, and at what temperature?
A: MAGLUMI PIVKA-II reagents should be stored immediately upon receipt between 2 to 8 degrees Celsius to maintain their efficacy throughout their shelf life.
Q: Where can MAGLUMI PIVKA-II (CLIA) reagents be sourced in India?
A: These reagents are available from authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers throughout India. This widespread availability facilitates straightforward procurement for laboratories nationwide.
Q: What is the process for running a test using MAGLUMI PIVKA-II (CLIA) reagents?
A: Samples are loaded into the MAGLUMI CLIA analyzer along with the reagent. The instrument performs automated chemiluminescence immunoassays, generating quantitative and real-time results for clinical decision-making.
Q: How does using this reagent benefit laboratory operations?
A: The reagent's high specificity and reliable performance contribute to reduced retesting, more accurate diagnostics, and faster turnaround times, ultimately supporting excellence in laboratory operations.